Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.

TGF-β (transforming growth factor-β) is a pleiotropic cytokine regulating diverse cellular processes. It signals through membrane-bound receptors, downstream Smad proteins and/or other signalling mediators. Smad7 has been well established to be a key negative regulator of TGF-β signalling. It antagonizes TGF-β signalling through multiple mechanisms in the cytoplasm and in the nucleus. Smad7 can be transcriptionally induced by TGF-β and other growth factors and serves as an important cross-talk mediator of the TGF-β signalling pathway with other signalling pathways. Accordingly, it plays pivotal roles in embryonic development and adult homoeostasis, and altered expression of Smad7 is often associated with human diseases, such as cancer, tissue fibrosis and inflammatory diseases.

[1]  C. Albanese,et al.  Smad7 restricts melanoma invasion by restoring N‐cadherin expression and establishing heterotypic cell–cell interactions in vivo , 2010, Pigment cell & melanoma research.

[2]  K. Miyazono,et al.  Smad7 Inhibits Transforming Growth Factor-β Family Type I Receptors through Two Distinct Modes of Interaction* , 2010, The Journal of Biological Chemistry.

[3]  Hyun-A Seong,et al.  Murine Protein Serine/Threonine Kinase 38 Stimulates TGF-β Signaling in a Kinase-dependent Manner via Direct Phosphorylation of Smad Proteins* , 2010, The Journal of Biological Chemistry.

[4]  Li Yang,et al.  TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression. , 2010, Trends in immunology.

[5]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[6]  Zhenzhen Wang,et al.  In Vivo Disruption of TGF-β Signaling by Smad7 in Airway Epithelium Alleviates Allergic Asthma but Aggravates Lung Carcinogenesis in Mouse , 2010, PloS one.

[7]  S. Park,et al.  Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling. , 2010, Biochemical and biophysical research communications.

[8]  J. C. McDermott,et al.  Nuclear Function of Smad7 Promotes Myogenesis , 2009, Molecular and Cellular Biology.

[9]  Michael K. Wendt,et al.  Mechanisms of the epithelial-mesenchymal transition by TGF-beta. , 2009, Future oncology.

[10]  F. Chen,et al.  Human BAMBI Cooperates with Smad7 to Inhibit Transforming Growth Factor-β Signaling* , 2009, The Journal of Biological Chemistry.

[11]  R. Derynck,et al.  New regulatory mechanisms of TGF-beta receptor function. , 2009, Trends in cell biology.

[12]  Judy H. Cho,et al.  Interleukin-23/Th17 pathways and inflammatory bowel disease. , 2009, Inflammatory bowel diseases.

[13]  Takeru Yoshimura,et al.  Increased IκBα expression is essential for the tolerogenic property of TGF‐β‐exposed APCS , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  Ziying Liu,et al.  Regulation of TGF-β signaling by Smad7 , 2009, Acta biochimica et biophysica Sinica.

[15]  Zhenzhen Wang,et al.  Smad7 Is Required for the Development and Function of the Heart* , 2009, Journal of Biological Chemistry.

[16]  F. Chen,et al.  Study of interaction between Smad7 and DNA by single-molecule force spectroscopy. , 2008, Biochemical and biophysical research communications.

[17]  Ye Guang Chen,et al.  Specific Activation of Mitogen-activated Protein Kinase by Transforming Growth Factor-␤ Receptors in Lipid Rafts Is Required for Epithelial Cell Plasticity Transforming Growth Factor (tgf)-␤ Regulates a Spectrum of Cellular Events, including Cell Proliferation, Differentiation, and Migration. in Add , 2008 .

[18]  J. Yang,et al.  Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55 , 2008, Oncogene.

[19]  H. Yoshikawa,et al.  Smad7 Inhibits Chondrocyte Differentiation at Multiple Steps during Endochondral Bone Formation and Down-regulates p38 MAPK Pathways*♦ , 2008, Journal of Biological Chemistry.

[20]  C. Heldin,et al.  The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner , 2008, Nature Cell Biology.

[21]  M. Yamashita,et al.  TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. , 2008, Molecular cell.

[22]  T. Clemens,et al.  Smad7 Stabilizes β-Catenin Binding to E-cadherin Complex and Promotes Cell-Cell Adhesion* , 2008, Journal of Biological Chemistry.

[23]  C. Heldin,et al.  Jcb: Report , 2022 .

[24]  N. Deane,et al.  Smad7 induces hepatic metastasis in colorectal cancer , 2008, British Journal of Cancer.

[25]  R. Flavell,et al.  TGF-β: A Master of All T Cell Trades , 2008, Cell.

[26]  J. Massagué,et al.  TGFβ in Cancer , 2008, Cell.

[27]  Xin-Hua Feng,et al.  Critical regulation of TGFβ signaling by Hsp90 , 2008, Proceedings of the National Academy of Sciences.

[28]  K. Krieglstein,et al.  Tieg3/Klf11 induces apoptosis in OLI‐neu cells and enhances the TGF‐β signaling pathway by transcriptional repression of Smad7 , 2008, Journal of cellular biochemistry.

[29]  E. Mizoguchi,et al.  Inflammatory bowel disease, past, present and future: lessons from animal models , 2008, Journal of Gastroenterology.

[30]  G. Glazner,et al.  TGF-β1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis , 2008, Neuroscience Letters.

[31]  Bernhard Schmierer,et al.  TGFβ–SMAD signal transduction: molecular specificity and functional flexibility , 2007, Nature Reviews Molecular Cell Biology.

[32]  Oliver Sieber,et al.  A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk , 2007, Nature Genetics.

[33]  Y. Wan,et al.  Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy , 2007, Clinical Cancer Research.

[34]  Shi-Long Lu,et al.  Distinct roles of individual Smads in skin carcinogenesis , 2007, Molecular carcinogenesis.

[35]  U. Bogdahn,et al.  Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis , 2007, Journal of Neuroimmunology.

[36]  S. Park,et al.  Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2 , 2007, Nature Immunology.

[37]  Feng Chen,et al.  Smad7 Antagonizes Transforming Growth Factor β Signaling in the Nucleus by Interfering with Functional Smad-DNA Complex Formation , 2007, Molecular and Cellular Biology.

[38]  P. Dijke,et al.  Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .

[39]  K. Mohammad,et al.  Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. , 2007, Cancer research.

[40]  P. Zhou,et al.  Activation of extracellular signal-regulated kinase by TGF-β1 via TβRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells , 2007, Cell Biology and Toxicology.

[41]  S. Iwata,et al.  Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7 , 2007, Oncogene.

[42]  F. Ruscetti,et al.  Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells , 2007, Platelets.

[43]  U. Hellman,et al.  Methylation of Smad6 by protein arginine N‐methyltransferase 1 , 2006, FEBS letters.

[44]  W. Mikulits,et al.  Activated hepatic stellate cells induce tumor progression of neoplastic hepatocytes in a TGF‐β dependent fashion , 2006, Journal of cellular physiology.

[45]  P. Dijke,et al.  Smad7-Induced β-Catenin Degradation Alters Epidermal Appendage Development , 2006 .

[46]  R. Beauchamp,et al.  Role of Smad proteins in the regulation of NF-κB by TGF-β in colon cancer cells , 2006 .

[47]  T. Pawson,et al.  Deletion of Exon I of SMAD7 in Mice Results in Altered B Cell Responses , 2006, The Journal of Immunology.

[48]  Jiahuai Han,et al.  Axin is a scaffold protein in TGF‐β signaling that promotes degradation of Smad7 by Arkadia , 2006, The EMBO journal.

[49]  Fumiko Itoh,et al.  Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells , 2006, BMC Cell Biology.

[50]  Zhenzhen Wang,et al.  In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  K. Miyazono,et al.  Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells. , 2005, Journal of the National Cancer Institute.

[52]  I. Fidler,et al.  Blockade of the TGF-beta superfamily by Smad7: breaking a link in the metastatic chain. , 2005, Journal of the National Cancer Institute.

[53]  L. Larue,et al.  Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo , 2005, Oncogene.

[54]  A. Strasser,et al.  Transforming Growth Factor β-Dependent Sequential Activation of Smad, Bim, and Caspase-9 Mediates Physiological Apoptosis in Gastric Epithelial Cells , 2005 .

[55]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[56]  A. Mauviel,et al.  Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis , 2005, Oncogene.

[57]  Jiri Zavadil,et al.  TGF-β and epithelial-to-mesenchymal transitions , 2005, Oncogene.

[58]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[59]  J. Wrana,et al.  Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. , 2005, Molecular cell.

[60]  F. Lallemand,et al.  AIP4 Restricts Transforming Growth Factor-β Signaling through a Ubiquitination-independent Mechanism* , 2005, Journal of Biological Chemistry.

[61]  R. Beauchamp,et al.  Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis. , 2005, Experimental cell research.

[62]  K. Miyazono,et al.  Degradation of the Tumor Suppressor Smad4 by WW and HECT Domain Ubiquitin Ligases* , 2005, Journal of Biological Chemistry.

[63]  Maria Simonsson,et al.  The Balance between Acetylation and Deacetylation Controls Smad7 Stability* , 2005, Journal of Biological Chemistry.

[64]  Fang Liu,et al.  Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7. , 2005, Journal of the American Society of Nephrology : JASN.

[65]  M. Landström,et al.  2-Methoxyestradiol-induced Apoptosis in Prostate Cancer Cells Requires Smad7* , 2005, Journal of Biological Chemistry.

[66]  H. Lan,et al.  Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney. , 2005, Kidney international. Supplement.

[67]  K. Miyazono,et al.  NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor , 2005 .

[68]  J. Voorhees,et al.  Ultraviolet Irradiation Induces Smad7 via Induction of Transcription Factor AP-1 in Human Skin Fibroblasts* , 2005, Journal of Biological Chemistry.

[69]  A. Mariani,et al.  Overexpression of the TGF-β antagonist Smad7 in endometrial cancer , 2005 .

[70]  C. Heldin,et al.  Interaction between Smad7 and β-Catenin: Importance for Transforming Growth Factor β-Induced Apoptosis , 2005, Molecular and Cellular Biology.

[71]  A. Sánchez-Capelo.  Dual role for TGF-β1 in apoptosis , 2005 .

[72]  S. Park.  Fine Tuning and Cross-talking of TGF-β Signal by Inhibitory Smads , 2005 .

[73]  F. Lallemand,et al.  The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation , 2004, The EMBO journal.

[74]  K. Miyazono,et al.  Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1) , 2004, Oncogene.

[75]  K. Miyazono,et al.  Roles for the MH2 Domain of Smad7 in the Specific Inhibition of Transforming Growth Factor-β Superfamily Signaling* , 2004, Journal of Biological Chemistry.

[76]  A. Ishisaki,et al.  Expressions of inhibitory Smads, Smad6 and Smad7, are differentially regulated by TPA in human lung fibroblast cells. , 2004, Biochemical and biophysical research communications.

[77]  C. Heldin,et al.  Smad7 is required for TGF-β-induced activation of the small GTPase Cdc42 , 2004, Journal of Cell Science.

[78]  S. Park,et al.  Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation , 2004, Molecular and Cellular Biology.

[79]  T. Macdonald,et al.  A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation* , 2004, Journal of Biological Chemistry.

[80]  Xu Cao,et al.  GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor , 2004, The Journal of cell biology.

[81]  H. Ihn,et al.  Impaired Smad7-Smurf-mediated negative regulation of TGF-beta signaling in scleroderma fibroblasts. , 2004, The Journal of clinical investigation.

[82]  Takeshi Imamura,et al.  Arkadia amplifies TGF‐β superfamily signalling through degradation of Smad7 , 2003 .

[83]  Xin-Hua Feng,et al.  Smad6 Recruits Transcription Corepressor CtBP To Repress Bone Morphogenetic Protein-Induced Transcription , 2003, Molecular and Cellular Biology.

[84]  Jennifer Lee,et al.  Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma. , 2003, Cancer research.

[85]  A. Mariani,et al.  HER2/Neu- and TAK1-mediated Up-regulation of the Transforming Growth Factor β Inhibitor Smad7 via the ETS Protein ER81* , 2003, Journal of Biological Chemistry.

[86]  K. Miyazono,et al.  Cooperative inhibition of bone morphogenetic protein signaling by Smurf1 and inhibitory Smads. , 2003, Molecular biology of the cell.

[87]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[88]  E. Kimura,et al.  Expression of Smad4 and Smad7 in human thyroid follicular carcinoma cell lines , 2003, Journal of endocrinological investigation.

[89]  Jeffrey L. Wrana,et al.  Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.

[90]  C. Heldin,et al.  Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3. , 2003, Molecular biology of the cell.

[91]  K. Miyazono,et al.  Smurf1 Regulates the Inhibitory Activity of Smad7 by Targeting Smad7 to the Plasma Membrane* 210 , 2002, The Journal of Biological Chemistry.

[92]  Y. Terada,et al.  Smad7 mediates transforming growth factor-β–induced apoptosis in mesangial cells , 2002 .

[93]  Ulf Hellman,et al.  Control of Smad7 stability by competition between acetylation and ubiquitination. , 2002, Molecular cell.

[94]  J. Voorhees,et al.  Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. , 2002, The Journal of investigative dermatology.

[95]  A. Nakao,et al.  Smad7: a new key player in TGF-β-associated disease , 2002 .

[96]  F. Lallemand,et al.  Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling , 2002, Oncogene.

[97]  Stephen C. Jones,et al.  Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart. , 2002, American journal of physiology. Heart and circulatory physiology.

[98]  P. Goldschmidt-Clermont,et al.  Deficient Smad7 expression: A putative molecular defect in scleroderma , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[99]  Xu Cao,et al.  A Nuclear Antagonistic Mechanism of Inhibitory Smads in Transforming Growth Factor-β Signaling* , 2002, The Journal of Biological Chemistry.

[100]  K. Miyazono,et al.  The N domain of Smad7 is essential for specific inhibition of transforming growth factor-β signaling , 2001, The Journal of cell biology.

[101]  H. Suzuki,et al.  Involvement of MAP kinase cascades in Smad7 transcriptional regulation. , 2001, Biochemical and biophysical research communications.

[102]  F. Lallemand,et al.  Evidence for a Role of the JNK Cascade in Smad7-mediated Apoptosis* , 2001, The Journal of Biological Chemistry.

[103]  E. Bottinger,et al.  Apoptosis in podocytes induced by TGF-β and Smad7 , 2001 .

[104]  T. Macdonald,et al.  Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease. , 2001, The Journal of clinical investigation.

[105]  J. Voorhees,et al.  Ultraviolet Irradiation Blocks Cellular Responses to Transforming Growth Factor-β by Down-regulating Its Type-II Receptor and Inducing Smad7* , 2001, The Journal of Biological Chemistry.

[106]  C. Heldin,et al.  Phosphorylation of Smad7 at Ser-249 Does Not Interfere with Its Inhibitory Role in Transforming Growth Factor-β-dependent Signaling but Affects Smad7-dependent Transcriptional Activation* , 2001, The Journal of Biological Chemistry.

[107]  Tomoki Chiba,et al.  Smurf1 Interacts with Transforming Growth Factor-β Type I Receptor through Smad7 and Induces Receptor Degradation* , 2001, The Journal of Biological Chemistry.

[108]  F. Lallemand,et al.  Smad7 inhibits the survival nuclear factor κB and potentiates apoptosis in epithelial cells , 2001, Oncogene.

[109]  T. Nakayama,et al.  Dissection of inhibitory Smad proteins: both N- and C-terminal domains are necessary for full activities of Xenopus Smad6 and Smad7 , 2001, Mechanisms of Development.

[110]  R. Derynck,et al.  Smad7 Is Induced by CD40 and Protects WEHI 231 B-lymphocytes from Transforming Growth Factor-β-induced Growth Inhibition and Apoptosis* , 2000, The Journal of Biological Chemistry.

[111]  J. Wrana,et al.  Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. , 2000, Molecular cell.

[112]  H. Lodish,et al.  Synergism between Transcription Factors TFE3 and Smad3 in Transforming Growth Factor-β-induced Transcription of theSmad7 Gene* , 2000, The Journal of Biological Chemistry.

[113]  S. Dooley,et al.  Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. , 2000, The Journal of biological chemistry.

[114]  C. Heldin,et al.  Efficient TGF-β Induction of the Smad7 Gene Requires Cooperation between AP-1, Sp1, and Smad Proteins on the Mouse Smad7 Promoter* , 2000, The Journal of Biological Chemistry.

[115]  D. He,et al.  Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[116]  Harold L. Moses,et al.  STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling , 2000, Molecular and Cellular Biology.

[117]  C. Heldin,et al.  Smad7 mediates apoptosis induced by transforming growth factor β in prostatic carcinoma cells , 2000, Current Biology.

[118]  M. Bitzer,et al.  Smad3 and Smad4 Mediate Transcriptional Activation of the Human Smad7 Promoter by Transforming Growth Factor β* , 2000, The Journal of Biological Chemistry.

[119]  Xu Cao,et al.  Smad6 as a Transcriptional Corepressor* , 2000, The Journal of Biological Chemistry.

[120]  E. Bottinger,et al.  A mechanism of suppression of TGF–β/SMAD signaling by NF-κB/RelA , 2000, Genes & Development.

[121]  H. Friess,et al.  The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer , 1999, Oncogene.

[122]  M. Arsura,et al.  The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[123]  J. Massagué,et al.  Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway , 1999, Nature.

[124]  J. Massagué,et al.  Smad1 Recognition and Activation by the ALK1 Group of Transforming Growth Factor-β Family Receptors* , 1999, The Journal of Biological Chemistry.

[125]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[126]  C. Heldin,et al.  Physical and Functional Interaction of Murine andXenopus Smad7 with Bone Morphogenetic Protein Receptors and Transforming Growth Factor-β Receptors* , 1998, The Journal of Biological Chemistry.

[127]  C. Heldin,et al.  Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. , 1998, Biochemical and biophysical research communications.

[128]  J. Massagué,et al.  Determinants of specificity in TGF-beta signal transduction. , 1998, Genes & development.

[129]  C. Heldin,et al.  Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling , 1997, Nature.

[130]  C. J. Gimeno,et al.  Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[131]  J. Wrana,et al.  The MAD-Related Protein Smad7 Associates with the TGFβ Receptor and Functions as an Antagonist of TGFβ Signaling , 1997, Cell.

[132]  M. Arsura,et al.  TGFβ1 Inhibits NF-κB/Rel Activity Inducing Apoptosis of B Cells: Transcriptional Activation of IκBα , 1996 .

[133]  H. Huber,et al.  Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence. , 2010, The American journal of pathology.

[134]  Ying E Zhang,et al.  Non-Smad pathways in TGF-β signaling , 2009, Cell Research.

[135]  Xiao-Fan Wang,et al.  Signaling cross-talk between TGF-β/BMP and other pathways , 2009, Cell Research.

[136]  S. Barry,et al.  Foxp3+ Regulatory T Cells, Th17 Effector Cells, and Cytokine Environment in Inflammatory Bowel Disease , 2009, Journal of Clinical Immunology.

[137]  A. Moustakas,et al.  Regulating the stability of TGFβ receptors and Smads , 2009, Cell Research.

[138]  久米 真司.  SIRT1 inhibits transforming growth factor β-induced apoptosis in glomerular mesangial cells via Smad7 deacetylation , 2007 .

[139]  T. Gress,et al.  Smad – Sp 1 complexes mediate TGF b-induced early transcription of oncogenic Smad 7 in pancreatic cancer cells , 2006 .

[140]  多嶋 佳孝.  Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-β signaling by Smad7 , 2004 .

[141]  高河 慎介.  Sustained activation of fibroblast transforming growth factor-β/Smad signaling in a murine model of scleroderma , 2003 .

[142]  C. Heldin,et al.  Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors. , 1998, The Journal of biological chemistry.

[143]  J. Massagué.  TGF-beta signal transduction. , 1998, Annual review of biochemistry.